Loading...
A trial of venous thromboembolism prophylaxis after hip or knee arthroplasty did not show that aspirin was noninferior to rivaroxaban or warfarin for symptomatic VTE or death. Warfarin and rivaroxaban were not noninferior to aspirin for safety.